oral glp 1 inhibitor Orforglipron, an Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes Comparison of GLP-1 receptor agonists

One of the cornerstones in therapy for the prevention of acute cardiovascular events in patients with high plasma LDL-c is statins

DT: Writing original draft, Writing review and editing

Experts hope the new approvals will help prevent shortages triggered by demand for injectable weight loss and type 2 diabetes drugs, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)

Protein, fiber, and exercise: a narrative review of their roles in weight management and cardiometabolic health

Semaglutidethe active ingredient in both Wegovy and compounded formulationsactivates GLP-1 receptors that regulate appetite and blood sugar

Let's Do the Math: Step-by-Step Calculation Now, let's get practical